Clinical Trial Update: A Follow-up Study on Safety and Tolerability of Intracerebroventricular Administration of sNN0031 to Patients With Parkinson's Disease

View source ↗

Summary

This update reports on a completed follow-up study evaluating the safety and tolerability of intracerebroventricularly administered sNN0031 in patients with Par…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• sNN0031

Snippet

Sponsor: Newron Sweden AB | Conditions: Parkinson's Disease | Status: COMPLETED